|
RWDD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.416500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.031780E-01 |
| Normal-vs-Stage2 |
8.514400E-02 |
| Normal-vs-Stage3 |
1.995170E-03 |
| Normal-vs-Stage4 |
1.436450E-03 |
| Stage1-vs-Stage2 |
4.773800E-01 |
| Stage1-vs-Stage3 |
6.470500E-02 |
| Stage1-vs-Stage4 |
3.018100E-02 |
| Stage2-vs-Stage3 |
5.399000E-01 |
| Stage2-vs-Stage4 |
2.481800E-01 |
| Stage3-vs-Stage4 |
4.269200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.877600E-03 |
| Normal-vs-AfricanAmerican |
1.849370E-01 |
| Normal-vs-Asian |
1.894650E-01 |
| Caucasian-vs-AfricanAmerican |
8.803200E-01 |
| Caucasian-vs-Asian |
4.855200E-01 |
| AfricanAmerican-vs-Asian |
7.270400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.463400E-01 |
| Normal-vs-Female |
2.541400E-03 |
| Male-vs-Female |
1.688570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.593600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.359900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.311880E-02 |
| Normal-vs-Age(81-100Yrs) |
2.002400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.833600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.373350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.217920E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.330400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.557840E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.808100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.701520E-02 |
| Classical-VS-Follicular |
7.247200E-01 |
| Classical-VS-Other |
4.314100E-02 |
| Classical-VS-Normal |
3.542300E-02 |
| Tall-VS-Follicular |
1.674420E-02 |
| Tall-VS-Other |
1.801500E-03 |
| Tall-VS-Normal |
1.365770E-04 |
| Follicular-VS-Other |
1.837220E-01 |
| Follicular-VS-Normal |
2.706800E-01 |
| Other-VS-Normal |
3.055000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.519760E-02 |
| Normal-vs-N1 |
1.942600E-01 |
| N0-vs-N1 |
7.469000E-01 |
|
|
